Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1186 AL 1200

A brief overview of amyloids and Alzheimer's disease

Ow SY, Dunstan DE.

Protein Sci. 2014 Oct;23(10):1315-31. doi: 10.1002/pro.2524. Epub 2014 Jul 30.

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

Beekes M, Thomzig A, Schulz-Schaeffer WJ, Burger R.

Acta Neuropathol. 2014 Oct;128(4):463-76. doi: 10.1007/s00401-014-1324-9. Epub 2014 Jul 30.

Genomic aspects of sporadic neurodegenerative diseases

Mitsui J, Tsuji S.

Biochem Biophys Res Commun. 2014 Sep 19;452(2):221-5. doi: 10.1016/j.bbrc.2014.07.098. Epub 2014 Jul 28.

Recommendations of the Alzheimer's disease-related dementias conference

Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, Sieber BA, Silverberg NB, Sutherland M, Torborg CL, Waddy SP, Zlokovic BV, Corriveau RA; ADRD 2013 Conference Organizing Committee.

Neurology. 2014 Aug 26;83(9):851-60. doi: 10.1212/WNL.0000000000000733. Epub 2014 Jul 30.

Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies

Tang W, Huang Q, Wang Y, Wang ZY, Yao YY.

J Neurol Sci. 2014 Oct 15;345(1-2):26-36. doi: 10.1016/j.jns.2014.07.015. Epub 2014 Jul 15.

Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration

Oeckl P, Steinacker P, von Arnim CA, Straub S, Nagl M, Feneberg E, Weishaupt JH, Ludolph AC, Otto M.

J Proteome Res. 2014 Nov 7;13(11):4518-25. doi: 10.1021/pr5006058. Epub 2014 Aug 13.

Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease

Qiu L, Zhang W, Tan EK, Zeng L.

ACS Chem Neurosci. 2014 Oct 15;5(10):884-94. doi: 10.1021/cn500149w. Epub 2014 Sep 25.

Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease

Meyer PM, Tiepolt S, Barthel H, Hesse S, Sabri O.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):376-86. Epub 2014 Nov 11.

Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders

Bañuelos-Cabrera I, Valle-Dorado MG, Aldana BI, Orozco-Suárez SA, Rocha L.

Arch Med Res. 2014 Nov;45(8):677-86. doi: 10.1016/j.arcmed.2014.11.010. Epub 2014 Nov 20.

Donepezil-induced myoclonus in a patient with Alzheimer disease

Bougea A, Gerakoulis S, Anagnostou E, Paraskevas G, Kapaki E, Kararizou E.

Ann Pharmacother. 2014 Dec;48(12):1659-61. doi: 10.1177/1060028014550334. Epub 2014 Sep 8.

Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors

Ikeda K, Yanagihashi M, Sawada M, Hanashiro S, Kawabe K, Iwasaki Y.

Intern Med. 2014;53(9):1007-10. doi: 10.2169/internalmedicine.53.1857. Epub 2014 May 1.

Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation

Kamal MA, Priyamvada S, Anbazhagan AN, Jabir NR, Tabrez S, Greig NH.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):338-46. doi: 10.2174/18715273113126660137.

Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease

Song J, Park KA, Lee WT, Lee JE.

Int J Mol Sci. 2014 Jan 29;15(2):2119-29. doi: 10.3390/ijms15022119.

Lipid integration in neurodegeneration: an overview of Alzheimer's disease

Yadav RS, Tiwari NK.

Mol Neurobiol. 2014 Aug;50(1):168-76. doi: 10.1007/s12035-014-8661-5. Epub 2014 Mar 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias